Recruiting NCT06731504
HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT
Hematologic Malignancy
Hematology
3,640 trials in this section
Recruiting NCT06712459
Integrated Molecular and Clinical Profiling of Transformed Splenic Marginal Zone Lymphoma
Transformed Splenic Marginal Zone Lymphoma
Recruiting NCT05512390
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
Diffuse Large B-Cell Lymphoma · Chronic Lymphocytic Leukemia · Follicular Lymphoma
Recruiting NCT07006025
A Study of Oral Tetrahydrouridine-Decitabine in Relapsed or Refractory Myelodysplastic Syndromes (MDS)
MDS
Recruiting NCT06197165
Amylo-Shiatsu-Acute-Chronic: Effects of Shiatsu on Symptoms and Quality of Life of Amyloidosis Patients
Cardiac Amyloidosis
Recruiting NCT05512169
Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia
ALL, Childhood · Pediatric Cancer · Toxicity, Drug
Not yet recruiting NCT07345000
A Study of Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic Anemia
Treatment-naïve Severe Aplastic Anemia
Recruiting NCT06429449
Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia
Leukemia · Myeloid Leukemia · Monocytic Leukemia
Not yet recruiting NCT07343687
Clinico-hematological and Coagulation Profiles in Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Intensive Induction Chemotherapy .
Acute Myeloid Leukemia
Recruiting NCT06647732
Zanubrutinib Plus Rituximab as Front-line Treatment for Mucosa-associated Lymphoid Tissue Lymphoma (MALT)
Mucosa-associated Lymphoid Tissue Lymphoma (MALT)
Recruiting NCT06004011
AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)
Cervical Cancer · Kaposi Sarcoma · Non Hodgkin Lymphoma
Recruiting NCT05287568
CC-486 and Venetoclax for Acute Myeloid Leukemia
AML
Not yet recruiting NCT07339527
EZH2 Inhibitor Zeprumetostat in Combination Therapy for Patients With Relapsed or Refractory Mature T-cell and NK-cell Lymphomas
Mature T-cell and NK-cell Lymphoma
Recruiting NCT04220970
Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry
Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL)
Recruiting NCT07341815
Parental Support Intervention in an Advanced Oncological Context
Metastatic Cancer · Cancer Recurrence · Hematological Cancer
Recruiting NCT05922501
Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma
Relapsed Cancer · Refractory Multiple Myeloma · Multiple Myeloma
Recruiting NCT07338604
Clinical Study of UTAA07 Injection in the Treatment of Hematologic and Lymphatic Systemic Malignancies
Hematolymphoid Malignancies
Recruiting NCT06573723
Institutional Registry of Rare Diseases
Rare Diseases · Amyloidosis · Sarcoidosis
Not yet recruiting NCT07337967
Reticulocyte Parameters as Early Indicators of Bone Marrow Erythropoietic Activity in Chronic B Lymphoproliferative Neoplasms
B Chronic Lymphocytic Leukemia
Recruiting NCT07336823
JY232(JY232) Injection in Relapsed/Refractory Multiple Myeloma
Multiple Myeloma
Not yet recruiting NCT07334574
Clinical Study of XP-006 mRNA Vaccine for R/R B-NHL
B-cell Non-Hodgkin's Lymphoma (B-NHL)
Recruiting NCT06755450
Study Evaluating Safety Pharmacokinetics and Pharmacodynamics of AUR112 in Patients With Relapsed Advanced Lymphoma
Relapsed Advanced Lymphomas
Recruiting NCT05006482
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
Lymphoma · Malignant Solid Neoplasm
Not yet recruiting NCT07333469
A Clinical Study of HX111 in Patients With Advanced Solid Tumor and Lymphoma
Solid Tumor and Lymphoma
Not yet recruiting NCT07338422
HID-HSCT Versus IST as First-line Treatment for SAA
Aplastic Anaemia
Not yet recruiting NCT07334535
Isa-VRD in TIE HRMM
Multiple Myeloma
Recruiting NCT05317403
Venetoclax to Augment Epigenetic Modification and Chemotherapy
Acute Myeloid Leukemia, in Relapse · Acute Myeloid Leukemia Refractory
Recruiting NCT07335120
A Real-world Data and Sample Compendium of Frail and/or Multiply Treated Large B-cell Lymphoma
DLBCL
Recruiting NCT05524298
Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma
Low Grade Non-Hodgkin's Lymphoma, Adult
Recruiting NCT06627751
Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease
Extramedullary Disease in Multiple Myeloma · Recurrent Multiple Myeloma · Refractory Multiple Myeloma
Recruiting NCT03829254
A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma
Advanced Cancer · Lymphoma · Solid Tumor
Recruiting NCT06163430
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
Chronic Myeloid Leukemia, Chronic Phase · Chronic Myeloid Leukemia
Recruiting NCT05188170
Niclosamide in Pediatric Patients With Relapsed and Refractory AML
Acute Myeloid Leukemia (AML)
Recruiting NCT05934084
Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors
Classical Hodgkin Lymphoma · Diffuse Large B Cell Lymphoma (DLBCL) · Primary Mediastinal Large B-cell Lymphoma (PMBCL)
Recruiting NCT05270096
International Leukemia Target Board
Relapsed Hematologic Malignancy · Refractory Hematologic Malignancy
Not yet recruiting NCT07330895
Clinical Study of LV009 Injection in the Treatment of Recurrent/Refractory CD19 Positive Blood Tumors
CD19+ Relapse/Refractory B-ALL
Recruiting NCT06776952
A Randomized, Double-blind, Multicenter Phase III Study of XNW5004 Tablets in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
Relapsed/Refractory Peripheral T Cell Lymphoma
Recruiting NCT04872478
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
Acute Myeloid Leukemia · Acute Lymphoblastic Leukemia · Mixed Phenotype Acute Leukemia
Not yet recruiting NCT07320534
Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase
Neutropenic Fever · Acute Lymphoblastic Leukemia
Recruiting NCT04640987
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback
Hematologic Diseases
Recruiting NCT07326930
Tracjectories and Predictors of Chemotherapy Induced Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia ALL
Recruiting NCT07327138
Children's Laughter and Fun Yoga as Adjunctive Pain Relief Following Chemotherapy.
Acute Lymphoblastic Leukemia ALL
Recruiting NCT06910124
Linvoseltamab in Addition to Lenalidomide (L2) During Maintenance Therapy of NDMM to Deepen Responses or Redrive MRD Negativity After Relapse
Multiple Myeloma
Recruiting NCT06122389
SHR2554 Clinical Study of Chidamide in the Treatment of T-cell Lymphoma
Relapsed/Refractory PTCLT With at Least One Line of Prior Systemic Therapy
Recruiting NCT05342584
Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS
Acute Myeloid Leukemia · Myelodysplastic Syndromes
Recruiting NCT05597306
Venetoclax and Bomedemstat in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Acute Myeloid Leukemia · Refractory Acute Myeloid Leukemia · Acute Myeloid Leukemia, in Relapse
Recruiting NCT04448184
Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial)
Hematologic Neoplasms
Recruiting NCT06043674
Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
Chronic Lymphocytic Leukemia · Richter's Transformation
Not yet recruiting NCT07322159
IASO206 in Patients With Relapsed/Refractory Multiple Myeloma
Relapsed/Refractory Multiple Myeloma (RRMM)
Recruiting NCT06685848
Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion
Hematologic Neoplasms
Recruiting NCT07306949
Real-Life Clinical Efficacy of Acoramidis in Participants With ATTR-CM and Association With Cardiac Biomarkers
Transthyretin-type Cardiac Amyloidosis
Recruiting NCT05417165
Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma
Not yet recruiting NCT07319481
Preliminary Effectiveness and Feasibility of Transcutaneous Acupoints Electrical Stimulation on Chemotherapy-induced Peripheral Neuropathy Among Children With Acute Lymphoblastic Leukemia
Chemotherapy Induced Peripheral Neuropathy (CIPN)
Recruiting NCT07108998
Study of Epcoritamab as a Consolidation Therapy in CLL/SLL
CLL/SLL · CLL · SLL
Not yet recruiting NCT07316920
A Clinical Study of of RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas
Relapsed/Refractory B-cell Lymphoma
Not yet recruiting NCT07319793
Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCT
Acute Myeloid Leukemia · Myelodysplastic Syndromes (MDS)
Recruiting NCT06514768
JY231 (JY231) Injection for the Treatment of B-cell Acute Lymphoblastic Leukemia (B-ALL)
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Recruiting NCT02442011
Hematology Biobank: In Vitro Study of Blood Disorders
Hematological Disorders
Recruiting NCT07014917
Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · CLL Variant
Recruiting NCT02835911
Clinical Cohort of Lymphoma Patients in Malawi
Lymphoma · Hematologic Malignancies
Recruiting NCT05184842
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
Myelodysplastic Syndromes · Acute Myeloid Leukemia · Chronic Myelomonocytic Leukemia
Recruiting NCT05757310
A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia
Recurrent Severe Aplastic Anemia · Refractory Severe Aplastic Anemia
Recruiting NCT06054776
Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
Mantle Cell Lymphoma
Recruiting NCT05722405
Ixazomib Plus Low-dose Lenalidomide Versus Ixazomib Alone for Maintenance Treatment of High Risk Multiple Myeloma
Multiple Myeloma
Recruiting NCT06220032
Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma
DLBCL - Diffuse Large B Cell Lymphoma
Recruiting NCT05819528
Primary Cardiac Lymphoma: Italian Multicenter Experience
Primary Cardiac Lymphoma
Recruiting NCT01853631
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
Non-Hodgkin Lymphoma · Chronic Lymphocytic Leukemia · Acute Lymphocytic Leukemia
Recruiting NCT06883526
Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma
Lymphoma
Recruiting NCT05249959
Consolidation With Loncastuximab Tesirine After a Short Course of Immunochemotherapy in BTKi-treated (or Intolerant) Relapsed/Refractory Mantle Cell Lymphoma Patients.
Relapsed Mantle Cell Lymphoma · Refractory Mantle Cell Lymphoma
Recruiting NCT01252485
Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms - The Biology and Outcome (BiO)-Project
Acute Myeloid Leukemia (AML) · MDS/AML
Recruiting NCT07313943
PAX5-NEGATIVE HODGKIN-LIKE LYMPHOMAS: A DIAGNOSTIC CHALLANGE
Hodgkin or Non-Hodgkin Lymphoma
Recruiting NCT06649253
Childhood B-acute Lymphoblastic Leukaemia and Role of CD9 Gene Regulation in Relapse
Leukemia, Lymphoblastic, Acute, Pediatric
Recruiting NCT07313982
LEF1 EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A MARKER FOR DIAGNOSIS AND SURVIVAL PREDICTION
Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)
Recruiting NCT07138547
GSL Synthetase Inhibitor Eliglustat Combined With CD30 Target Immunotherapy for the Treatment of of CD30+ Lymphoma
Lymphoma
Recruiting NCT07314268
ATTR Amyloid Cardiomyopathy: Characterization of Extracellular Vesicles as Potential Disease Stratifiers and Prognostic Biomarkers
Wild-type ATTR Amyloidosis · Amyloidosis Cardiac · Amyloidosis, Hereditary
Recruiting NCT06393361
Chidamide Decitabine Plus Anti-PD-1 Antibody for Patients With R/R cHL Who Are Transplant-ineligible or Refused Transplant.
Ineligible Or Refused Transplant Patients With Classical Hodgkin Lymphoma
Recruiting NCT07313878
Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization Microscopy
Acute Lymphoblastic Leukaemias (ALL) · Long Term Follow-Up
Recruiting NCT06835530
A Combination of Rituximab and CC-99282 as Front-line Therapy for Older Frail Patients With Diffuse Large B-cells Non-Hodgkin Lymphoma Evaluated With a Simplified Geriatric Assessment (sGA): a Phase II Study of the Fondazione Italiana Linfomi (FIL)
Diffuse Large B Cell Non-Hodgkin Lymphoma
Recruiting NCT07173595
A Phase I Study of QLS2309 Injection in Patients With CD70+ Relapsed/Refractory Hematologic Malignancies
Relapsed or Refractory Hematologic Malignancies
Recruiting NCT07312630
Clinical Study of LV009 Injection for the Treatment of Relapsed/Refractory CD19-Positive Hematologic and Lymphoid Malignancies
Non-Hodgkin Lymphoma (NHL) · Acute Lymphoblastic Leukemia (ALL), Adult
Recruiting NCT06452732
Using Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in P-AML
Acute Myeloid Leukemia · Acute Lymphoblastic Leukemia
Recruiting NCT07093710
Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma
Peripheral T Cell Lymphoma
Recruiting NCT04991103
Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
Multiple Myeloma · Amyloidosis
Recruiting NCT07312188
A Study of F182112 in the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Recruiting NCT06366789
Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia
AML With Gene Mutations
Recruiting NCT07131254
A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in Adult Participants With Relapsed/Refractory CD19-positive B-cell Malignant Hematological Tumors
Hematological Malignancy (Leukemia- Lymphoma)
Recruiting NCT00177268
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
Cutaneous T-cell Lymphoma · Sezary Syndrome · Mycosis Fungoides
Recruiting NCT04792502
Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma
Follicular Lymphoma · Marginal Zone Lymphoma · B-cell Lymphoma
Not yet recruiting NCT07310186
Treatment and Outcomes of DLBCL After Progression on Polatuzumab Vedotin-based Combination Therapy
Diffuse Large B Cell Lymphoma (DLBCL)
Recruiting NCT07297576
Safety and Feasibility of Sulforaphane to Promote Early Haematopoietic Recovery After Cord Blood Transplantation
ALL (Acute B-Lymphoblastic Leukemia) · AML (Acute Myelogenous Leukemia · MDS (Myelodysplastic Syndrome)
Recruiting NCT05816850
Multilayer Biological Characterization of Advanced Follicular Lymphoma: a Translational Study From FIL_FOLL12 Trial
Follicular Lymphoma
Not yet recruiting NCT07296445
A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokinetics, Safety, and Efficacy (LATITUDE/SDKARS-301)
Acute Promyelocytic Leukemia (APL) · Acute Promyelocytic Leukaemia · Acute Promyelocytic Leukemia With PML-RARA
Recruiting NCT06008691
A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice
Non-Hodgkin Lymphoma, B-cell
Not yet recruiting NCT07276230
Quality of Life Assessment of Caregivers of Patients With Multiple Myeloma
Caregivers of Patients With Multiple Myeloma
Recruiting NCT06588205
Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma
Diffuse Large B Cell Lymphoma · High-grade B-cell Lymphoma · High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Enrolling by invitation NCT04428489
Follow-up Study of ICUS and CCUS Patients
Myelodysplastic Syndromes
Recruiting NCT07100067
LCAR-F33S in Treatment of Relapsed/Refractory Multiple Myeloma
Relapsed/Refractory Multiple Myeloma(MM)
Recruiting NCT05657652
CAV Regimen for R/R Ph- B-ALL
Acute Lymphoblastic Leukemia
Recruiting NCT03326310
Selumetinib and Azacitidine in High Risk Chronic Blood Cancers
Chronic Myeloid Leukemia · Myelofibroses
Recruiting NCT05657639
CAV Regimen for R/R AML
Acute Myeloid Leukemia